Expected wait times for access to a disease-modifying Alzheimer's treatment in England: A modelling study.

The NHS England lacks capacity to provide timely access to a disease-modifying treatment, which is estimated to result in significant wait times and potentially avoidable disease progression. Better diagnostic tools at initial evaluation may reduce delays.